Lagging demand for the iPhone X and reports from smartphone chipmakers of decreased orders has some analysts predicting that Apple will retire its most expensive phone.
Mirabaud analyst [Neil Campling](https://www.cnbc.com/2018/04/20/apple-iphone-x-discontinued-this-year-analyst-says.html) said he anticipates the iPhone X will likely be discontinued this year.
According to Sascha Segan, lead analyst for PCMag.com, that's not going to happen. Instead, Segan said that Apple would launch new iPhones in the fall and the X would live on as the premium iPhone on the market.
"We are going to do a little flipping here," said Segan. "You have this prestige position where the X is, and then the 11 and then the 12 possibly."
When asked if the X is worthy of that prestige position, Segan said, "No, I never thought the iPhone X was worth a thousand dollars."
The iPhone X is still the most profitable iPhone despite underwhelming demand. Segan said that Apple was testing consumers' limits with the iPhone X. But he thinks the company will keep pushing those limits.
For full interview, [click here](https://cheddar.com/videos/iphone-x-dead).
Nugget ice is booming across America. Middleby CEO Tim FitzGerald explains the craze, restaurant demand and why the trend could become a major growth engine.
Wearable robotics are moving beyond sci-fi. Dephy CEO Luke Mooney explains how its smart ankle exoskeleton is changing mobility, recovery and everyday movement.
Voice AI is moving into cars, restaurants and customer service. SoundHound CEO Keyvan Mohajer explains the company’s growth and the future of voice-powered AI.
Americans are still spending, but rising anxiety over jobs, AI, housing and tariffs tells a different story. Kearney Consumer Institute’s Katie Thomas explains.
Disney is back in focus after Q3 earnings. Investors are watching streaming profits, theme parks and ESPN as the entertainment giant looks for its next catalyst
Healthcare policy is shifting fast, raising questions about drug prices, Medicare and access. Leap Health CEO Hani Elias explains what patients need to know.
